Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

10/4/2025

Janusmed sex and gender

Janusmed sex and gender – azithromycin monohydrate

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Azithromycin testing environment

Azithromycin

Class : A

Show all info

Print

Contact us

  1. Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. Clin Infect Dis. 2015;61:1389-99.

  2. Beyda RM, Benjamins LJ, Symanski E, Swartz M, Risser WL, Eissa M. Azithromycin efficacy in the treatment of Chlamydia trachomatis among detained youth. Sex Transm Dis. 2014;41:592-4.

  3. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497-502.

  4. Handsfield HH, Dalu ZA, Martin DH, Douglas JM, McCarty JM, Schlossberg D. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhea Azithromycin Gonorrhea Study Group. Sex Transm Dis. 1994;21:107-11.

  5. Coeman M, van Durme Y, Bauters F, Deschepper E, Demedts I, Smeets P et al. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study. Ther Adv Respir Dis. 2011;5:377-86.

  6. Han MK, Tayob N, Murray S, Dransfield MT, Washko G, Scanlon PD et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med. 2014;189:1503-8.

  7. Maniakas A, Desrosiers M. Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit. Am J Rhinol Allergy. 2014;28:151-5.

  8. Svanström H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013;368:1704-12.

  9. AZITROMAX (azithromycin). Summary of Product Characteristics. Swedish Medical Products Agency; 2015.

  10. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-22.

  11. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.]

  1. Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. Clin Infect Dis. 2015;61:1389-99.
  2. Beyda RM, Benjamins LJ, Symanski E, Swartz M, Risser WL, Eissa M. Azithromycin efficacy in the treatment of Chlamydia trachomatis among detained youth. Sex Transm Dis. 2014;41:592-4.
  3. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497-502.
  4. Handsfield HH, Dalu ZA, Martin DH, Douglas JM, McCarty JM, Schlossberg D. Multicenter trial of single-dose azithromycin vs ceftriaxone in the treatment of uncomplicated gonorrhea Azithromycin Gonorrhea Study Group. Sex Transm Dis. 1994;21:107-11.
  5. Coeman M, van Durme Y, Bauters F, Deschepper E, Demedts I, Smeets P et al. Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study. Ther Adv Respir Dis. 2011;5:377-86.
  6. Han MK, Tayob N, Murray S, Dransfield MT, Washko G, Scanlon PD et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med. 2014;189:1503-8.
  7. Maniakas A, Desrosiers M. Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit. Am J Rhinol Allergy. 2014;28:151-5.
  8. Svanström H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013;368:1704-12.
  9. AZITROMAX (azithromycin). Summary of Product Characteristics. Swedish Medical Products Agency; 2015.
  10. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-22.
  11. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.]